Zimmer Announces Acquisition of Synvasive Technology, Inc.

WARSAW, Ind., Jan. 12, 2012 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE and SIX:
ZMH) announced today that it has acquired Reno, Nevada-based Synvasive
Technology, Inc. The acquisition will enhance Zimmer’s product portfolio through
the addition of Synvasive’s STABLECUT® surgical saw blades, as well as the
eLIBRA® Dynamic Knee Balancing System(TM) for soft tissue balancing.

“Zimmer is committed to developing the industry’s most innovative range of
technologies to support personalized therapies, from improved surgical power
equipment to patient specific instrumentation and other intelligent tools that
support optimal surgical outcomes,” said Jeff McCaulley, President, Zimmer
Reconstructive. “The acquisition of Synvasive Technology further strengthens our
surgical resection and advanced instrumentation offerings.”

In the surgical resection market, Synvasive has long been recognized as a leader
in surgical cutting tools with its STABLECUT® blades. Synvasive’s eLIBRA®
Dynamic Knee Balancing System(TM) is the premiere soft-tissue balancing solution
in the industry. This offering provides patient specific soft-tissue balancing
during knee replacement surgery, establishing the optimal position of the
femoral implant to enable a less-invasive surgical approach as well as excellent
stability, range of motion and patella tracking.

About Zimmer

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops,
manufactures and markets orthopaedic reconstructive, spinal and trauma devices,
dental implants, and related surgical products. Zimmer has operations in more
than 25 countries around the world and sells products in more than 100
countries. Zimmer’s 2010 sales were approximately $4.2 billion. The Company is
supported by the efforts of more than 8,000 employees worldwide.

About Synvasive Technology

Located in Reno, Nevada, Synvasive Technology, Inc. develops, manufactures and
distributes patented and proprietary instruments enhancing reconstructive
orthopaedic surgery. For nearly twenty years, Synvasive has been a provider of
some of the most advanced surgical cutting technology in the market. Synvasive
is the exclusive provider of the patented large bone surgical saw blades,
STABLECUT®, an industry gold standard.

Website Information

We routinely post important information for investors on our website,
www.zimmer.com, in the “Investor Relations” section. We intend to use this
website as a means of disclosing material, non-public information and for
complying with our disclosure obligations under Regulation FD. Accordingly,
investors should monitor the Investor Relations section of our website, in
addition to following our press releases, SEC filings, public conference calls,
presentations and webcasts. The information contained on, or that may be
accessed through, our website is not incorporated by reference into, and is not
a part of, this document.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 based on
current expectations, estimates, forecasts and projections about the
orthopaedics industry, management’s beliefs and assumptions made by management.
Forward-looking statements may be identified by the use of forward-looking terms
such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,”
“estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and
“seeks” or the negative of such terms or other variations on such terms or
comparable terminology. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that could cause
actual outcomes and results to differ materially. For a list and description of
such risks and uncertainties, see our periodic reports filed with the U.S.
Securities and Exchange Commission. We disclaim any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be set forth in our
periodic reports. Readers of this document are cautioned not to place undue
reliance on these forward-looking statements, since, while we believe the
assumptions on which the forward-looking statements are based are reasonable,
there can be no assurance that these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all forward-looking
statements contained in this document.